What are the primary and secondary differential diagnoses of nephrotic syndrome and which history questions should be asked when taking a clinical history for a patient with suspected nephrotic syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Differential Diagnosis and Clinical History Taking for Nephrotic Syndrome

When evaluating a patient with suspected nephrotic syndrome, systematically distinguish between primary (idiopathic) and secondary causes through targeted history questions, as this distinction fundamentally determines whether immunosuppressive therapy is appropriate or potentially harmful 1.

Primary Differential Diagnoses

Adults

  • Membranous nephropathy (most common primary cause in adults)
  • Focal segmental glomerulosclerosis (FSGS) (second most common)
  • Minimal change disease (MCD) (less common in adults than children)

Children

  • Minimal change disease (most common, ~80% of cases)
  • Focal segmental glomerulosclerosis
  • Membranous nephropathy (rare in children)

Secondary Causes to Rule Out

Systemic Diseases

  • Diabetes mellitus (diabetic nephropathy)
  • Systemic lupus erythematosus (lupus nephritis)
  • Amyloidosis
  • Multiple myeloma/paraproteinemias

Infections

  • HIV infection (HIV-associated nephropathy)
  • Hepatitis B and C
  • Syphilis
  • Malaria

Medications/Toxins

  • NSAIDs
  • Gold therapy
  • Penicillamine
  • Lithium
  • Heroin (heroin nephropathy)

Malignancies

  • Solid tumors (lung, colon, breast, renal cell carcinoma)
  • Hematologic malignancies (Hodgkin lymphoma, leukemia)

Adaptive/Hemodynamic (Secondary FSGS)

  • Obesity (obesity-related glomerulopathy)
  • Reduced nephron mass (prematurity, reflux nephropathy, unilateral renal agenesis)
  • Sickle cell disease
  • Cyanotic congenital heart disease

Essential History Questions for Clinical Practical Examination

Presenting Symptoms

  • "When did you first notice swelling?" (onset and progression of edema)
  • "Where is the swelling located?" (periorbital, lower extremities, generalized anasarca)
  • "Have you noticed foamy or frothy urine?" (suggests heavy proteinuria)
  • "Have you experienced unusual fatigue or weakness?"

Distinguishing Primary from Secondary FSGS 1

  • "What is your current weight? Has it changed recently?" (obesity suggests secondary FSGS)
  • "Were you born prematurely or told you had kidney problems as a baby?" (reduced nephron mass)
  • "Do you have diabetes or high blood pressure?" (secondary causes)

Family History (Critical for Genetic Forms)

  • "Does anyone in your family have kidney disease, especially at a young age?" (genetic FSGS)
  • "Has anyone in your family needed dialysis or kidney transplant?"
  • "Are your parents related to each other?" (consanguinity increases genetic risk)

Medication and Drug History

  • "What medications are you currently taking, including over-the-counter drugs?" (NSAIDs, herbal supplements)
  • "Have you used any recreational drugs, particularly heroin?"
  • "Have you been treated with gold, penicillamine, or lithium?"

Systemic Disease Screening

  • "Have you had any rashes, joint pain, or mouth ulcers?" (lupus)
  • "Do you have diabetes? When was it diagnosed?"
  • "Have you had unexplained fevers, night sweats, or weight loss?" (malignancy, infection)
  • "Have you been diagnosed with HIV, hepatitis B, or hepatitis C?"

Infection History

  • "Have you had any recent infections, particularly strep throat or skin infections?" (post-infectious GN)
  • "Have you traveled to areas with endemic infections?" (malaria, schistosomiasis)
  • "Have you had tuberculosis or been exposed to TB?" (screen before immunosuppression) 2

Thrombotic Risk Assessment

  • "Have you had any leg pain, swelling in one leg more than the other, or shortness of breath?" (venous thromboembolism risk, especially with albumin <2.9 g/dL) 2

Cardiovascular and Renal History

  • "Do you have high blood pressure? When did it start?" (new-onset hypertension suggests glomerular disease)
  • "Have you noticed blood in your urine?" (hematuria suggests nephritic component)
  • "Have you had kidney stones or urinary tract infections?"

Functional Status and Quality of Life

  • "How has this affected your daily activities?" (assess disability from nephrotic syndrome)
  • "Are you able to work/attend school?"
  • "Do you have difficulty breathing when lying flat?" (volume overload)

Critical Clinical Clues from History

Suggests Primary (Idiopathic) Disease

  • Acute onset in previously healthy individual
  • No systemic symptoms
  • Negative family history
  • Young age at presentation
  • Severe nephrotic syndrome (proteinuria >8-10 g/day, albumin <3.0 g/dL)

Suggests Secondary Disease 1

  • Obesity (BMI >30)
  • Known diabetes, hypertension, or autoimmune disease
  • Gradual onset
  • Relatively preserved albumin (>3.0 g/dL) despite proteinuria
  • Sub-nephrotic proteinuria (<3.5 g/day)
  • History of prematurity or congenital kidney abnormalities

Red Flags Requiring Urgent Evaluation

  • Rapidly rising creatinine (>30% increase in 6-12 months) 3
  • Severe symptoms (life-threatening edema, respiratory compromise)
  • Signs of thrombosis (unilateral leg swelling, chest pain, dyspnea)
  • Fever with immunosuppression (infection risk) 2

Common Pitfalls to Avoid

  1. Assuming all nephrotic syndrome is primary: Always exclude secondary causes before starting immunosuppression, as treatment differs fundamentally 1

  2. Missing obesity-related FSGS: Patients with BMI >30, relatively normal albumin, and hilar variant FSGS on biopsy likely have secondary disease requiring weight loss, not immunosuppression 3

  3. Overlooking medication causes: NSAIDs and other drugs can cause MCD or FSGS; discontinuation may be curative

  4. Failing to screen for infections before immunosuppression: Screen for latent TB, hepatitis B/C, HIV, and Strongyloides (if at risk) before starting treatment 2

  5. Not assessing thrombotic risk: Albumin <2.9 g/dL significantly increases VTE risk, particularly in membranous nephropathy 2

  6. Ignoring genetic testing indications: Family history of kidney disease, consanguinity, or early-onset disease warrant genetic evaluation, as monogenic mutations may not respond to immunosuppression 1, 2

Age-Specific Considerations

Children

  • MCD is presumed if age <12 years with typical presentation; treat empirically with steroids without biopsy 4
  • Biopsy indicated only if steroid-resistant or atypical features
  • Genetic testing more relevant in children with steroid resistance

Adults

  • Biopsy typically required for diagnosis (exception: positive anti-PLA2R antibodies diagnostic of membranous nephropathy) 4, 5
  • Higher likelihood of secondary causes
  • Greater steroid intolerance (consider CNIs as first-line if diabetes, psychiatric disease, or severe osteoporosis) 1, 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.